Protalix Biotherapeutics (PLX)

Protalix (PLX) Financial Statements


Protalix Financial Overview

Protalix's market cap is currently ―. The company's EPS TTM is $-0.312; its P/E ratio is -6.70; Protalix is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 9.59M-$ 14.18M$ 8.75M$ 16.09M
Gross Profit$ 6.50M-$ 7.11M$ 4.67M$ 10.05M
EBIT$ -2.94M-$ -2.93M$ -4.71M$ -1.67M
EBITDA$ -2.58M-$ -2.65M$ -4.44M$ -1.40M
Net Income Common Stockholders$ -3.13M-$ -3.57M$ -5.33M$ -2.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.04M$ 17.11M$ 20.81M$ 28.57M$ 32.92M
Total Assets$ 66.56M$ 55.79M$ 56.71M$ 60.64M$ 68.39M
Total Debt$ 33.57M$ 33.47M$ 33.14M$ 33.01M$ 33.40M
Net Debt$ 532.00K$ 16.36M$ 12.33M$ 4.43M$ 481.00K
Total Liabilities$ 65.55M$ 55.79M$ 68.22M$ 70.53M$ 75.88M
Stockholders Equity$ 1.01M$ -10.64M$ -11.51M$ -9.89M$ -7.49M
Cash Flow-
Free Cash Flow$ -3.25M-$ -9.26M$ -7.48M$ -6.06M
Operating Cash Flow$ -3.00M-$ -9.20M$ -7.36M$ -5.83M
Investing Cash Flow$ 4.73M-$ 5.91M$ 357.00K$ -16.26M
Financing Cash Flow$ 14.23M-$ 1.52M$ 2.64M$ 0.00
Currency in USD

Protalix Earnings and Revenue History

Protalix Debt to Assets

Protalix Cash Flow

Protalix Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis